Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Rationale The stop-signal reaction time (SSRT) task measures inhibition of a response that has already been initiated, i.e. the ability to stop. 'Impulsive' human subjects, e.g. with attention deficit and hyperactivity disorder (ADHD), have longer SSRTs. Both SSRT and go-trial reaction time (GoRT) may be sensitive to drugs such as d-amphetamine, methylphenidate and modafinil, both in normal subjects and those with ADHD.Objectives To investigate the effects of modafinil (3, 10, 30 and 100 mg/kg) and methylphenidate (0.3, 1.0 and 3.0 mg/kg) on SSRT task performance in the rat. To investigate the possible contribution of dopamine receptors in the action of these drugs using the mixed D1/D2 dopamine receptor antagonist cis-flupenthixol.Results Modafinil significantly decreased SSRT with little effect on GoRT but only in rats with slow baseline SSRTs. Fast SSRTs were not changed by modafinil. Methylphenidate decreased GoRTs of all rats. However, methylphenidate had baseline-dependent effects on SSRT, decreasing SSRT in slow responders but increasing SSRT in fast responders. Cis-flupenthixol (0.01, 0.04 and 0.125 mg/kg) had no effects on SSRT but increased GoRT at higher doses. At the lowest dose (0.01 mg/kg), cis-flupenthixol failed to disrupt the SSRT-decreasing effects of either modafinil or methylphenidate, whereas at 0.04 mg/kg, the cis-flupenthixol-dependent increase in GoRT was antagonised by methylphenidate but not by modafinil.Conclusions This evidence supports a hypothesis that stop and go processes are under control of distinct neurochemical mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Administration of methylphenidate and atomoxetine, which both target the dopamine and noradrenalin system, by inhibiting the re-uptake from the synaptic cleft, decreased SSRT in humans and in animals, raising the possibility that noradrenalin is involved in motor response inhibition as well (Chamberlain et al., 2006b; Eagle et al., 2007; Bari et al., 2009; Nandam et al., 2011).”
From Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders (2014) · cites this paper as Eagle et al., 2007
In the citing paper
“MPH is also effective in increasing response inhibition in rats (Eagle et al 2007, Navarra et al 2008)”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Eagle et al 2007
Citations
Cites
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · The Statistician · doi:10.2307/2348956 · Cited by 8,278
On the ability to inhibit thought and action: a theory of an act of control
Logan, G. D., & Cowan, W. B. (1984) · Psychological Review · doi:10.1037/0033-295x.91.3.295 · Cited by 2,590 · cited 4×
“SSRTs were estimated using the protocol described in Logan (1994), from the measures of stop-trial accuracy and the distribution of GoRTs for each rat for each session.”
BackgroundMethodInfluentialInhibitory Processes in Attention, Memory and Language
Carr, T. H., & Dagenbach, D. (1994) · Medical Entomology and Zoology · Cited by 2,362
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
Self-citationCharacterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170 · cited 2×
“Disruption of executive functions leading to impaired stopping may be the core deficit in ADHD (Barkley 1997; Turner 2006), although recently, a more integrative model of ADHD has been proposed, which includes stopping as one of several key executive function deficits within ADHD (Castellanos et al. 2006).”
BackgroundOn the ability to inhibit thought and action: A users' guide to the stop signal paradigm
Logan, G. D. (1994) · UvA-DARE (University of Amsterdam) · Cited by 1,115
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Attention Deficit Disorder: A Review of the Past 10 Years
CANTWELL, D. P. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199608000-00008 · Cited by 773 · cited 3×
“Although methylphenidate is a common treatment for symptoms of ADHD, both in children and adults, in up to 30% of cases, methylphenidate failed to improve ADHD symptoms and often increased SSRT in these subjects (Cantwell 1996; Krause et al. 2005).”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · cited 2×
“…(ADHD), where impulsive subjects have slower SSRTs. Disruption of executive functions leading to impaired stopping may be the core deficit in ADHD (Barkley 1997; Turner 2006), although recently, a more integrative model of ADHD has been proposed, which includes stopping as one of several key…”
BackgroundNeurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · cited 2×
“A recent study of atomoxetine treatment on the SSRT task implicated noradrenaline in the SSRT process, noradrenaline function within the prefrontal cortex being critical for several forms of behavioural control including inhibition (Arnsten and Dudley 2005; Arnsten and Li 2005), but not the GoRT process (Chamberlain e…”
BackgroundMethodSelf-citationCognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 515
Self-citationMethylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
Aron, A. R., Dowson, J. H., Sahakian, B. J., & Robbins, T. W. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00609-7 · Cited by 391
Self-citationArnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
TANNOCK, R., ICKOWICZ, A., & SCHACHAR, R. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199507000-00012 · Cited by 305
Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301
Self-citationEffect of Anxiety on Cognition, Behavior, and Stimulant Response in ADHD
PLISZKA, S. R. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198911000-00012 · Cited by 293 · cited 2×
“…ADHD subjects, and there are also reports that children with co-morbid anxiety/ internalising disorders are less likely to respond well to methylphenidate (Boonstra et al. 2005; Buitelaar et al. 1995; DuPaul et al. 1994; Pliszka 1989; Rapport et al. 1985a; Tannock et al. 1995; Taylor et al. 1987).”
BackgroundEffects of methylphenidate on inhibitory control in hyperactive children
Tannock, R., Schachar, R. J., Carr, R. P., Chajczyk, D., & Logan, G. D. (1989) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916508 · Cited by 290
Effects of d-Amphetamine and alcohol on a measure of behavioral inhibition in rats.
Feola, T. W., de Wit, H., & Richards, J. B. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.4.838 · Cited by 278
Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
Bastoji, H., & Jouvet, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90014-0 · Cited by 269
SEMRUD-CLIKEMAN, M., FILIPEK, P. A., BIEDERMAN, J., STEINGARD, R., KENNEDY, D., RENSHAW, P., & BEKKEN, K. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199407000-00014 · Cited by 261
Eagle, D. M., & Robbins, T. W. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1302 · Cited by 252
Self-citationTaylor, E., Schachar, R., Thorley, G., Wieselberg, H. M., Everitt, B., & Rutter, M. (1987) · Psychological Medicine · doi:10.1017/s0033291700013039 · Cited by 210
Lin, J. S., Roussel, B., Akaoka, H., Fort, P., Debilly, G., & Jouvet, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91713-o · Cited by 203
Langley, K., Marshall, L., van den Bree, M., Thomas, H., Owen, M., O’Donovan, M., & Thapar, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.133 · Cited by 183
TAYLOR, F. B., & RUSSO, J. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.311 · Cited by 180
The Effect of Methylphenidate on Three Forms of Response Inhibition in Boys with AD/HD
Scheres, A., Oosterlaan, J., Swanson, J., Morein-Zamir, S., Meiran, N., Schut, H., Vlasveld, L., & Sergeant, J. A. (2003) · Journal of Abnormal Child Psychology · doi:10.1023/a:1021729501230 · Cited by 176
Response of Children with ADHD to Methylphenidate: Interaction with Internalizing Symptoms
DuPAUL, G. J., BARKLEY, R. A., & McMURRAY, M. B. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199407000-00016 · Cited by 164
Modafinil: A Double-Blind Multicentric Study
Billiard, M., Besset, A., Montplaisir, J., Laffont, F., Goldenberg, F., Weill, J. S., & Lubin, S. (1994) · Sleep · doi:10.1093/sleep/17.suppl_8.s107 · Cited by 162
BUITELAAR, J. K., VAN DER GAAG, R. J., SWAAB-BARNKVHLD, H., & KUIPKR, M. A. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199508000-00012 · Cited by 160
Bedard, A.-C., Ickowicz, A., Logan, G. D., Hogg-Johnson, S., Schachar, R., & Tannock, R. (2003) · Journal of Abnormal Child Psychology · doi:10.1023/a:1023285614844 · Cited by 159
Boonstra, A. M., Kooij, J. J. S., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2005) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490515757 · Cited by 157
Overtoom, C. C. E., Verbaten, M. N., Kemner, C., Kenemans, J. L., van Engeland, H., Buitelaar, J. K., van der Molen, M. W., van der Gugten, J., Westenberg, H. G. M., Maes, R. A. A., et al. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00097-4 · Cited by 151
Eagle, D. M., & Robbins, T. W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.022 · Cited by 147
Self-citationSunohara, G., Malone, M. A., Rovet, J., Humphries, T., Roberts, W., & Taylor, M. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00023-8 · Cited by 143
Reaction Time Deficits and Parkinson's Disease
Gauntlett-Gilbert, J., & Brown, V. J. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00014-1 · Cited by 142
Effects of Modafinil in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label Study
Rugino, T. A., & COPLEY, T. C. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00018 · Cited by 122
Modafinil increases histamine release in the anterior hypothalamus of rats
Ishizuka, T., Sakamoto, Y., Sakurai, T., & Yamatodani, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00006-5 · Cited by 122
Modafinil affects mood, but not cognitive function, in healthy young volunteers
Randall, D. C., Shneerson, J. M., Plaha, K. K., & File, S. E. (2003) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.456 · Cited by 116
Schweitzer, J. B., Lee, D. O., Hanford, R. B., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300110 · Cited by 114
Rapport, M. D., Stoner, G., DuPaul, G. J., Birmingham, B. K., & Tucker, S. (1985) · Journal of Abnormal Child Psychology · doi:10.1007/bf00910644 · Cited by 109
Sustained Attention, Activation and MPH in ADHD: A Research Note
van der Meere, J., Shalev, R. S., Börger, N. A., & Gross‐Tsur, V. (1995) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1995.tb02323.x · Cited by 104
Gill, M., Haerich, P., Westcott, K., Godenick, K. L., & Tucker, J. A. (2006) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2006.tb01665.x · Cited by 96
Dopaminergic regulation of orexin neurons
Bubser, M., Fadel, J. R., Jackson, L. L., Meador‐Woodruff, J. H., Jing, D., & Deutch, A. Y. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04121.x · Cited by 95
Axelrod, J., Mueller, R. A., Henry, J. P., & STEPHENS, P. M. (1970) · Nature · doi:10.1038/2251059a0 · Cited by 95
Drugs for sleep disorders: mechanisms and therapeutic prospects
Szabadi, E. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02680.x · Cited by 89
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84
Modafinil in children with attention-deficit hyperactivity disorder
Rugino, T. A., & SAMSOCK, T. C. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(03)00148-6 · Cited by 81
The Neurobiological Basis of Movement Initiation
Lalonde, R., & Botez-Marquard, T. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.1.35 · Cited by 72
Waters, K. A., Burnham, K. E., O'Connor, D. V., Dawson, G. R., & Dias, R. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048995 · Cited by 68
Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins
Tanganelli, S., de la Mora, M. P., Ferraro, L., Méndez-Franco, J., Beani, L., Rambert, F. A., & Fuxé, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00675-w · Cited by 66
Effects of d-amphetamine in human models of information processing and inhibitory control
Fillmore, M. T., Kelly, T. H., & Martin, C. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.013 · Cited by 53
Dagan, Y., & Doljansky, J. T. (2006) · Chronobiology International · doi:10.1080/07420520600920734 · Cited by 47
Modafinil facilitates performance on a delayed nonmatching to position swim task in rats
Ward, C. P., Harsh, J., York, K. M., Stewart, K. L., & McCoy, J. G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.005 · Cited by 45
Lijffijt, M., Kenemans, J. L., Wal, A. T., Quik, E. H., Kemner, C., Westenberg, H., Verbaten, M. N., & van Engeland, H. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.04.003 · Cited by 41
Rapport, M. D., DuPaul, G. J., Stoner, G., Birmingham, B. K., & Masse, G. (1985) · Pediatrics · doi:10.1542/peds.76.6.938 · Cited by 41
A review of the use of modafinil for attention-deficit hyperactivity disorder
Turner, D. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.4.455 · Cited by 40
Sunohara, G., Voros, J. G., MALONE, M. A., & Taylor, M. J. (1997) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(97)00746-0 · Cited by 39
HENDLEY, E. D., SNYDER, S. H., FAULEY, J. J., & LaPIDUS, J. B. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29320-x · Cited by 37
Ross, S. B. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13218.x · Cited by 29
The Neuropharmacology Of Attention-Deficit Hyperactivity Disorder
Zametkin, A. J., & Borcherding, B. G. (1989) · Annual Review of Medicine · doi:10.1146/annurev.me.40.020189.002311 · Cited by 18
Meta-analysis in the assessment of treatment outcome
Geddes, J. R. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066056 · Cited by 7
Sustained Attention, Activation and MPH in ADHD: A Research Note
van der Meere, J., Shalev, R. S., Börger, N. A., & Gross‐Tsur, V. (1995) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1995.tb01320.x · Cited by 6
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Self-citationInsights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
The role of impulsive behavior in drug abuse
Perry, J. L., & Carroll, M. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1173-0 · Cited by 805
“2000), methylphenidate (Eagle et al. 2007), and modafinil (Eagle et al.”
BackgroundInfluentialModafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
“…effect on cis-flupenthixol-related m GoRT k SSRT in slow rats but m SSRT in fast rats; k go-trial RT in all rats; blocked cisflupenthixol-related m GoRT Eagle et al, 2007 Executive function and simple reaction time Humans 400 mg p.o. Amphetamine 20 mg p.o. k Simple RT, m WCST; no effect on verbal…”
BackgroundInfluentialEagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
“Recently, within one basic task framework, the SSRT has been measured alongside stop-trial commission errors (measured under a condition when the go and stop signals were presented together, the no-delay or zero-delay condition) (e.g. Eagle and Robbins 2003a; Eagle et al. 2007; Rubia et al. 2001; Schachar et al. 2007).”
MethodSelf-citation
Metadata
- Authors
- Eagle, D. M., Tufft, M. R. A., Goodchild, H. L., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Eagle, Dawn M.
- Venue
- Psychopharmacology
- Published
- 2007-02-03
- Volume
- 192
- Issue
- 2
- Pages
- 193-206
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2000655626
- Cited by
- 176
- References
- 64
- Citations by year
- 2025: 2 · 2022: 2 · 2021: 8 · 2020: 2 · 2019: 5 · 2018: 9 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 15 · 2013: 14 · 2012: 14
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Cambridge
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- modafinil, methylphenidate, stop-signal reaction time, response inhibition, dopamine receptors, cis-flupenthixol, attention deficit hyperactivity disorder, impulsivity
- MeSH terms
- Modafinil, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Behavior, Animal, Benzhydryl Compounds, Disease Models, Animal, Dose-Response Relationship, Drug, Flupenthixol, Impulsive Behavior, Inhibition, Psychological, Male, Methylphenidate, Psychomotor Performance, Reaction Time, Receptors, Dopamine, Dopamine Antagonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.